Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Quote

Not a forecast

“A reminder, this medical device is FDA approved, for use in children seven through 12, for the treatment of attention deficit hyperactivity disorder as a monotherapy. I suspect does quite a bit more than just that.”
· Frontier Update: Night 3 of Monarch eTNS Use Has Been Awesome · substack post

173-word update of 2023-10-03 after three nights using the Monarch eTNS trigeminal nerve stimulator for the author's own ADHD. He notes the device is FDA approved as ADHD monotherapy for children 7 through 12 and suspects it does quite a bit more than that.

Descriptive, retrospective, or a statement of preference; no future state asserted.